FLF Post-ICML Webinar

Join us for an informative webinar where we discuss some of the key topics covered during our Satellite Symposium held in June 2025, at the 18th International Conference of Malignant Lymphoma (ICML) in Lugano.

DATE: Wednesday 9th July

TIME: 2.00pm GMT | 9.00am ET | 11.00pm AEST

Our panellists will include one of the speakers from our 18-ICML symposium, Prof Jessica Okosun, FLF scientific Advisor, and Paul Mollitt, living with FL. Together we will explore what cure means, and the real progress being made to reach it. Key insights from the 18-ICML symposium will be discussed alongside what this means for patients today. Be sure to tune in to find out more!

Please see details below of the FLF Satellite Symposium that was held at the ICML conference:

What this webinar covers:

Whether you’re navigating FL yourself, supporting or caring for a loved one, this session will provide vital knowledge and expert guidance. Connect with others through this engaging discussion and ask your questions.

Stay tuned for more webinars covering other highly requested topics in the coming months!

About the speakers

Dr Mitchell Smith – Chief Medical Officer, Follicular Lymphoma Foundation

Dr Mitchell Smith has an extensive educational background, having earned his Medical Degree and PhD from Case Western Reserve University School of Medicine in Cleveland, OH. He has also completed several residencies and fellowships, including a Fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Centre in NY. Dr Smith’s career has also spanned many years and institutions, including serving as Director of the Lymphoma Program at Fox Chase Cancer Centre and Director of the Lymphoid Malignancy Program at the Cleveland Clinic. Join him as he shares his expert insights throughout our engaging webinar series.

Prof Jessica Okosun – Scientific Advisor, Follicular Lymphoma Foundation, Assistant Professor and Clinician Scientist, Barts Cancer Institute

Prof Okosun is a Consultant Haematologist at St Bartholomew’s Hospital, London UK specialising in lymphomas. Her research interests are focused on understanding how lymphomas initiate, diversify and evolve, particularly follicular lymphoma in a bid to define novel biomarkers and improve treatment. Jessica has been advising the FLF since February 2019.

Paul Christopher Mollitt – Diagnosed 2017

Paul was diagnosed with follicular lymphoma at age 35, after a massage therapist noticed a lump and encouraged him to get it checked. The diagnosis came as a huge shock, but over time, it led to a more intentional approach to life—helping him focus on what matters and live more in the moment. Originally diagnosed in London in 2017, Paul spent seven years on watch and wait, including two years in California, before settling in Spain. In December 2024, following more rapid growth and the discovery of a large abdominal tumour, he began first-line treatment with Bendamustine and Rituximab. He completed treatment in May 2025, achieving a full metabolic response. Paul now hopes for a long remission, giving time for advances in treatment and science—and more time to enjoy life.

This webinar is intended for educational and disease awareness purposes only and the information presented and discussed does not constitute medical advice.

This webinar series is supported by an educational grant from Genmab US, Inc and AbbVie and sponsorship from BeOne Medicines USA, Inc., and Novartis. All of the above have had no influence on, control of, nor input into the development or performance of the webinar series.